A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice.

Hanses, Frank; Dolff, Sebastian; Trauth, Janina; Seimetz, Michael; Hagel, Stefan

Hanses, Frank; Dolff, Sebastian; Trauth, Janina; Seimetz, Michael; Hagel, Stefan.

Afiliación

Hanses F; Emergency Department, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.
Dolff S; Department for Infectious Diseases and Infection Control, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.
Trauth J; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany.
Seimetz M; Division of Infectious Diseases, Department of Internal Medicine II, University Hospital Giessen and Marburg, Klinikstraße 33, 35392 Giessen, Germany.
Hagel S; Advanz Pharma Germany GmbH, Herforder Str. 69, 33602 Bielefeld, Germany.

Antibiotics (Basel) ; 11(5)2022 Apr 22.

Article en En | MEDLINE | ID: mdl-35625206

Palabras clave

acute bacterial skin and skin structure infection (ABSSSI); dalbavancin; real-world setting; registry

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies / Risk_factors_studies Idioma: En Revista: Antibiotics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google